Vaccination against pneumococcal infection in patients with diabetes mellitus

Tarasova A.A., Kostinov M.P., Novopoltseva E.G.

1) Privolzhsky Research Medical University, Nizhny Novgorod, Russia; 2) I.I. Mechnikov Research Institute of Vaccines and Serums, Moscow, Russia; 3) I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
The review highlights the relevance and necessity of vaccination against pneumococcal infection in the post-COVID period. A comparative analysis of vaccination schedules using conjugate and polysaccharide vaccines in patients with diabetes mellitus types 1 and 2 was carried out in accordance with foreign and domestic recommendations.

Keywords

diabetes mellitus
pneumococcal infection
pneumococcal conjugate vaccine
vaccination

About the Authors

Corresponding author: Alla A. Tarasova, Dr. Sci. (Med.), Professor, Department of Faculty and Outpatient Pediatrics, Privolzhsky Research Medical University, Nizhny Novgorod, Russia; taras.al@mail.ru

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.